annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) in the second quarter of fiscal 2025 were $2.43, up 29.2% year over year. The metric beat the Zacks Consensus Estimate by 5.6%.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, along with the income tax effect on those adjustments.
GAAP EPS in the reported quarter was $2.34, up 64.8% from the year-ago lev...
>>> Read more: ResMed Q2 Earnings and Revenues Beat, Stock Up in Pre-Market
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, along with the income tax effect on those adjustments.
GAAP EPS in the reported quarter was $2.34, up 64.8% from the year-ago lev...
>>> Read more: ResMed Q2 Earnings and Revenues Beat, Stock Up in Pre-Market
